{"schema_version":"secwatch.filing_event.v1","accession":"0001104659-24-113486","form_type":"8-K","ticker":"TLSI","cik":"0001826667","company_name":"TriSalus Life Sciences, Inc.","filed_at":"2024-11-01T23:59:59+00:00","discovered_at":"2026-05-14T18:03:09.866500+00:00","generated_at":"2026-05-30T07:02:10.902921+00:00","sec_items":["5.02"],"event_type":"leadership","sentiment":"negative","materiality_score":0.6,"calibrated_materiality_score":0.6,"confidence":"high","headline":"TriSalus: Director Anil Singhal resigns; CMO Steven Katz departs","bullets":["Director Anil Singhal resigned from Board, Compensation and Science/Technology committees effective Oct 28, 2024; no disagreement.","Chief Medical Officer Steven Katz left employment effective Oct 29, 2024.","No replacements announced for either role, creating two leadership vacancies."],"urls":{"canonical":"https://secwatch.observer/filing/0001104659-24-113486","json":"https://secwatch.observer/filing/0001104659-24-113486.json","markdown":"https://secwatch.observer/filing/0001104659-24-113486.md","text":"https://secwatch.observer/filing/0001104659-24-113486.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1826667/000110465924113486/0001104659-24-113486-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1826667/000110465924113486/tm2427190d1_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-30T07:02:10.902921+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"2a394e147d","claim":"Steven Katz departed as Chief Medical Officer at TriSalus Life Sciences, Inc..","evidence_excerpt":"Effective October 29, 2024, Steven Katz, M.D., the Company’s Chief Medical Officer, is no longer employed by the Company.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1826667/000110465924113486/0001104659-24-113486-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"no longer employed"},{"label":"Role","value":"Chief Medical Officer"}],"fact_type":"executive_change"},{"claim_id":"5e33f81480","claim":"Anil Singhal resigned as Director at TriSalus Life Sciences, Inc..","evidence_excerpt":"On October 28, 2024, Anil Singhal, Ph.D., informed the Board of Directors (the “Board”) of TriSalus Life Sciences, Inc. (the “Company”) of his decision to resign from his position as a member of the Board, the Compensation Committee of the Board and the Science and Technology Committee of the Board, effective immediately.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1826667/000110465924113486/0001104659-24-113486-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"resigned"},{"label":"Role","value":"Director"}],"fact_type":"executive_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}